← Back to catalogue

Irregular Rhythm Notification Feature (IRNF) Software

FDA 510(k)FDA UDIEUDAMED

Class II (US FDA 510(k))

510(k) K231173Ref Irregular Rhythm Notification Feature 2.XModel 2.X

by Apple Inc.

Identity

Trade Name
Irregular Rhythm Notification feature 2.0 FDA UDI
Generic Name
Self-care monitoring/reporting software FDA UDI
Device Name
Irregular Rhythm Notification Feature EUDAMED
Irregular Rhythm Notification feature Watch App (Version 2.0) FDA UDI
Model / Reference
2.X EUDAMED
Irregular Rhythm Notification Feature 2.X EUDAMED
Feature Version 2.x FDA UDI
Description
Irregular Rhythm Notification feature Watch App (Version 2.0) FDA UDI

Identifiers

Primary DI / UDI-DI
00194252456774 EUDAMEDFDA UDI
Basic UDI-DI
0194252IRNFeature22Q EUDAMED
Direct Marketing DI
00194252456774 EUDAMED
510(k) Number
K231173 FDA 510(k)
K212516 FDA UDI
FDA Product Code
QDB FDA 510(k)FDA UDI
EMDN Code
Z12039092 VARIOUS INSTRUMENTS TO SUPPORT AND MONITOR VITAL SIGNS - MEDICAL DEVICE SOFTWARE EUDAMED
GMDN Term
Self-care monitoring/reporting software FDA UDI

Classification

Device Class
Class IIa EUDAMED
Class II FDA 510(k)FDA UDI
Legislation / Framework
21 CFR Part 870.2790 FDA 510(k)
Regulation Number
870.2790 FDA 510(k)FDA UDI
Special Device Type
Software EUDAMED
Market of Registration
Ireland EUDAMED
Advisory Committee
Cardiovascular FDA 510(k)
FDA Decision
SESE Substantially Equivalent FDA 510(k)
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

EUDAMEDFDA UDI

Single Use

No

FDA UDI

Implantable

No

EUDAMEDFDA UDI

Reusable

No

EUDAMED

Contains Latex

No

EUDAMEDFDA UDI

Reprocessed

No

EUDAMED

CMR Substance

No

EUDAMED

Human-derived

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Endocrine Disruptor

No

EUDAMED

Administering Medicine

No

EUDAMED

Measuring Function

Yes

EUDAMED

Incorporates Medicinal Product

No

EUDAMED

Prescription Use

No

FDA UDI

Over-the-Counter

Yes

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

The Irregular Rhythm Notification Feature (IRNF) is a photoplethysmograph analysis software designed for over-the-counter use. It detects and alerts users to potential irregular heart rhythms through continuous monitoring via compatible wearable devices, functioning as a diagnostic aid for cardiovascular assessment.

Supplied as a digital application, the IRNF operates on compatible Apple devices and is intended for single-use per session without sterility requirements. It adheres to FDA 510(k) clearance (K231173) and EU MDR compliance, classified under device class II for cardiovascular monitoring. No physical storage or MRI safety considerations apply, as it is purely software-based.

Frequently asked questions

How does the Irregular Rhythm Notification Feature (IRNF) work and what wearable devices is it compatible with?

The IRNF is a software-based diagnostic aid that uses photoplethysmography (PPG) analysis to continuously monitor heart rhythms through compatible Apple wearable devices. It detects potential irregularities and alerts users via their Apple device, functioning as an over-the-counter tool for cardiovascular assessment. Compatibility is limited to Apple-branded wearables designed to support PPG monitoring.

Is the IRNF designed for repeated use or single sessions, and does it require sterilization?

The IRNF is intended for single-use per monitoring session, as it is a software application rather than a physical device. Since it operates digitally and does not involve direct patient contact or physical components, there are no sterility requirements. Users can restart the feature for new monitoring sessions as needed.

What regulatory approvals does the IRNF hold, and how does it classify under medical device regulations?

The IRNF holds FDA 510(k) clearance (K231173) and complies with EU MDR standards. It is classified as a Class II cardiovascular monitoring device under both regulatory frameworks, indicating it is intended for detecting potential irregular heart rhythms as a diagnostic aid.

Does the IRNF require any special storage conditions or considerations, such as MRI safety?

Since the IRNF is purely software-based and operates on Apple devices, no physical storage or environmental conditions (like temperature or humidity) are required. Additionally, there are no MRI safety concerns, as the feature does not involve hardware that could be affected by magnetic fields.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.

Authorization Coverage (2 countries)

Regulatory Authorizations

European Union Active

MDR

United States Active

FDA_510K

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Apple Inc.
FDA Applicant
Apple, Inc.

Sources (3)

  • FDA 510(k) K231173 24 fields · synced Sep 18, 2026
  • FDA UDI 8d8d9c39-a9d2-4ad2-b16b-738b1c53d626 34 fields · synced May 30, 2026
  • EUDAMED a4fad75f-4b5d-492e-a0c9-d084847a2166 61 fields · synced Jul 18, 2026